case_images: PMC9831652_01
case_images: Pancreatic tail/body cancer (red arrow) with multiple liver lesions.
case_images: rjac638f1.jpg
case_images: PMC9831652_01_rjac638f1.jpg
case_images: f1
case_images: Small peripancreatic lymph nodes were also noted (Fig. 1).
case_images: Status post-multimodal therapy with significant lesional downsizing or complete vanishing of cancerous lesions.
case_images: rjac638f2.jpg
case_images: PMC9831652_01_rjac638f2.jpg
case_images: f2
case_images: A follow-up CT scan confirmed that all remaining LMs in the right lobe had significantly decreased in size or vanished (Fig. 2).
case_images: Substantial CEA response after multimodal therapy.
case_images: rjac638f3.jpg
case_images: PMC9831652_01_rjac638f3.jpg
case_images: f3
case_images: Tumor markers (CA19-9 and CEA) decreased continuously to normal levels (Figs. 3 and 4).
case_images: Considerable CA19-9 response after multimodal therapy.
case_images: rjac638f4.jpg
case_images: PMC9831652_01_rjac638f4.jpg
case_images: f4
case_images: Tumor markers (CA19-9 and CEA) decreased continuously to normal levels (Figs. 3 and 4).
case_images: (A) Two brain metastases. (B) Status after surgical intervention on the bigger lesion.
case_images: rjac638f5.jpg
case_images: PMC9831652_01_rjac638f5.jpg
case_images: f5
case_images: Histology was consistent with metastatic PDAC (Fig. 5).